Literature DB >> 32234728

EMA advice on the use of NSAIDs for Covid-19.

.   

Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Health Care Quality, Access, and Evaluation; Primary Health Care

Year:  2020        PMID： 32234728     DOI： 10.1136/dtb.2020.000021

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN： 0012-6543


  9 in total

1.  [COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].

Authors:  A Janda; C Schuetz; M Heeg; K Minden; C M Hedrich; T Kallinich; C Hinze; A Schulz; F Speth
Journal:  Z Rheumatol       Date:  2020-09       Impact factor: 1.372

Review 2.  Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications.

Authors:  Anna M Fratta Pasini; Chiara Stranieri; Luciano Cominacini; Chiara Mozzini
Journal:  Antioxidants (Basel)       Date:  2021-02-10

Review 3.  Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy.

Authors:  Maurizio Gabrielli; Laura Franza; Alessandra Esperide; Irene Gasparrini; Antonio Gasbarrini; Francesco Franceschi
Journal:  Vaccines (Basel)       Date:  2022-01-26

Review 4.  A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.

Authors:  Lijuan Wang; Na Yang; Jinfeng Yang; Shuwu Zhao; Chen Su
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-10

5.  Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and relationship with mortality among United States Veterans after testing positive for COVID-19.

Authors:  Heather M Campbell; Allison E Murata; Todd A Conner; Greg Fotieo
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

6.  Ibuprofen use and clinical outcomes in COVID-19 patients.

Authors:  E Rinott; E Kozer; Y Shapira; A Bar-Haim; I Youngster
Journal:  Clin Microbiol Infect       Date:  2020-06-12       Impact factor: 8.067

Review 7.  Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.

Authors:  Mi Ryoung Seo; Ji-Won Kim; Eun-Jung Park; Seung Min Jung; Yoon-Kyoung Sung; Hyungjin Kim; Gunwoo Kim; Hyun-Sook Kim; Myeung-Su Lee; Jisoo Lee; Ji An Hur; Bum Sik Chin; Joong Sik Eom; Han Joo Baek
Journal:  Korean J Intern Med       Date:  2020-09-15       Impact factor: 2.884

Review 8.  Emerging treatment strategies for COVID-19 infection.

Authors:  Maria Gavriatopoulou; Ioannis Ntanasis-Stathopoulos; Eleni Korompoki; Despina Fotiou; Magdalini Migkou; Ioannis-Georgios Tzanninis; Theodora Psaltopoulou; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Clin Exp Med       Date:  2020-10-30       Impact factor: 3.984

Review 9.  Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19).

Authors:  Pablo Zubiaur; Dora Koller; Miriam Saiz-Rodríguez; Marcos Navares-Gómez; Francisco Abad-Santos
Journal:  Clin Transl Sci       Date:  2020-09-16       Impact factor: 4.689
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.